Login / Signup

Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach.

Ali RyanElena PolycarpouNathan A LackDimitrios D EvangelopoulosChristian SiegAlice HalmanSanjib BhaktaOlga EleftheriadouTimothy D McHughSebastian KeanyEdward D LoweRomain BalletAreej AbuhammadWilliam R JacobsAlessio CiulliEdith Sim
Published in: British journal of pharmacology (2017)
This article is part of a themed section on Drug Metabolism and Antibiotic Resistance in Micro-organisms. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.14/issuetoc.
Keyphrases
  • mycobacterium tuberculosis
  • adverse drug
  • drug induced
  • emergency department
  • benign prostatic hyperplasia
  • gram negative
  • human health
  • risk assessment